Jasper Therapeutics Financial Overview
Jasper Therapeutics's market cap is currently $49.25M. The company's EPS TTM is $-1.13; its P/E ratio is -0.30; Jasper Therapeutics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.67. See an overview of income statement, balance sheet, and cash flow financials.
